UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:November 14,
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more InVivo Therapeutics Charts.
InVivo Therapeutics (NASDAQ:NVIV)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more InVivo Therapeutics Charts.

Invivo Therapeutics Holdings Corp. News

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Thursday 21 March 2024 (1 month ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Tuesday 13 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)
Form DEF 14A - Other definitive proxy statements
Tuesday 5 December 2023 (5 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 1 December 2023 (5 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 30 November 2023 (5 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 8 November 2023 (6 months ago) • Edgar (US Regulatory)

More Invivo Therapeutics Holdings Corp. News Articles